Oppenheimer Upgrades Sarepta Therapeutics (SRPT) to Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DVLT

May 14, 2024 6:10 AM EDT
Get Alerts SRPT Hot Sheet
Price: $18.10 -1.74%

Rating Summary:
    19 Buy, 18 Hold, 6 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE

Oppenheimer analyst Hartaj Singh upgraded Sarepta Therapeutics (NASDAQ: SRPT) from Perform to Outperform with a price target of $180.00.


For an analyst ratings summary and ratings history on Sarepta Therapeutics click here. For more ratings news on Sarepta Therapeutics click here.


Shares of Sarepta Therapeutics closed at $131.70 yesterday.


You May Also Be Interested In





Related Categories

Upgrades